In silico assay development for screening of tetracyclic triterpenoids as anticancer agents against human breast cancer cell line MCF7.
Experimental activity of a compound on cancer cell line/target is mostly analyzed in the form of percentage inhibition at different concentration gradient and time of incubation. In this study a statistical model has been developed referred as in silico assay using support vector regression model, w...
Main Authors: | Om Prakash, Ateeque Ahmad, Vinay Kumar Tripathi, Sudeep Tandon, Aditya Bhusan Pant, Feroz Khan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4218838?pdf=render |
Similar Items
-
Tetracyclic triterpenoids as inhibitors of cytochrome P450 3A4 and their quantitative structure activity relationship analysis
by: Wei Pan, et al.
Published: (2023-10-01) -
In Silico Screening Anticancer of Six Triterpenoids toward miR-494 and TNF-α Targets
by: Vikra Ardiansyah Zaini, et al.
Published: (2020-04-01) -
Nanoformulations for Delivery of Pentacyclic Triterpenoids in Anticancer Therapies
by: Anna Kaps, et al.
Published: (2021-03-01) -
Antimicrobial and in silico studies of the triterpenoids of Dichapetalum albidum
by: Mary A. Chama, et al.
Published: (2023-07-01) -
Integracides: Tetracyclic Triterpenoids from <i>Fusarium</i> sp.—Their 5-Lipoxygenase Inhibitory Potential and Structure–Activity Relation Using In Vitro and Molecular Docking Studies
by: Maan T. Khayat, et al.
Published: (2022-12-01)